www.mayflowerbio.com
Sales & Support: 314-485-5210

*

GSK-690693 HCl

Supplier:
Catalogue number:
10-1310-01
Size:
5 mg
Product is available in:
  • USA
  • Canada
$98.00 Shipping is calculated in checkout

AKT inhibitor / A novel ATP-competitive pan-specific Akt kinase inhibitor. (IC50’s=2, 13, 9 nM for Akt1, 2 and 3 respectively) Antitumor activity. Active in vivo. Induces hyperglycemia. Cell permeable.

Product Type:

Biochemicals & reagents

CAS Number:

937174-76-0

Reference:

1) Rhodes et al. (2008), Characterization of an Akt kinase inhibitor with potent pharmacodynamics and antitumor activity; Cancer Res., 68 2366 2) Crouthamel et al. (2009), Mechanism and management of AKT inhibitor-induced hyperglycemia; Clin. Cancer Res., 15 217

Storage Temperature:

-20°C

Additional Information:

TARGET: Kinase -- PATHWAY: AKT -- DISEASE AREA: Diabetes; Cancer